Madison-based Exact Sciences, a provider of cancer screening and diagnostic tests, has entered into an agreement with Santa Clara, California-based Agilent Technologies to acquire one of its portfolio companies: Kirkland, Washington-based Resolution Biosciences.

Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. The company uses its “ctDx platform” to offer blood-based diagnostic tests, which Exact Sciences sees as complementary to its precision oncology portfolio.

Terms of the deal were not disclosed.

Click here to read the full article.